Hospitals are using AI to predict supply chain disruptions and make the best use of supplies before they expire.
The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk assessment procedures.
It is too early to say if ambient AI tools will yield a financial return on investment, according to a new report.
Dr. Karen DeSalvo, chief health officer at Google, said the company is working with partners to build trust in its AI models.
The company's AI tools help providers with chart reviews, risk adjustments and data processing.
Us2.ai's artificial intelligence software will be integrated into Fujifilm’s Lisendo 800 cardiovascular ultrasound.
Johnson & Johnson’s investment includes the construction of a $2 billion-plus biologics facility in North Carolina.
Health systems are investing in telehealth and remote patient monitoring by opening centralized digital health hubs.
Proscia sells digital pathology software and artificial intelligence tools to pharmaceutical companies and diagnostic laboratories at providers.
GE HealthCare's AI-powered Invenia Automated Breast Ultrasound Premium system is designed to improve breast cancer detection in women with dense breasts.
The company, formerly known as Allscripts, overstated its revenue in 2020 and 2022.
The recall, which affects two models of Pipeline Vantage embolization devices, is linked to 17 injuries and four deaths.
In the past few weeks, several health tech companies have launched AI tools to help organizations complete time intensive functions more efficiently.
Siemens Healthineers’ David Pacitti said the company wants to support health systems through long-term partnerships.